Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bausch + Lomb CEO Leaving 10 Weeks Following IPO, Month After Icahn Gains Two Board Seats

Jul 22 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

Valeant Launches Lumify OTC Eye Drops With Vision Of Better Days As Bausch

May 08 2018

Bausch CEO Papa Will Head Eye Health Biz Under Strategic Review

May 06 2021

Perrigo's Papa: Bridge Over Valeant's Troubled Waters Or Shark Bait?

May 02 2016

With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’

Feb 24 2021

Related Companies

Bausch Health Companies Inc.

Perrigo Company PLC

Additional Topics

Asia Pacific Europe International Middle East and Africa Canada United States Executive Changes M & A Consumer Advertising, Marketing & Sales Business Strategies Commercial Companies Dietary Supplements Manufacturing OTC Drugs

More from Leadership

More from HBW Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.